Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The current ratio is N/A as of Tuesday, October 6, 2026.
CURRENT RATIO
N/A
Market Cap
$1.40B
Current Ratio
11.11
TTM Avg
12.01
3Y Avg
12.01
5Y Avg
12.01
Market Cap
$1.40B
Current Ratio
17.76
TTM Avg
8.82
3Y Avg
5.82
5Y Avg
10.42
Market Cap
$1.42B
Current Ratio
1.73
TTM Avg
2.42
3Y Avg
2.71
5Y Avg
3.73
Market Cap
$1.45B
Current Ratio
3.02
TTM Avg
3.13
3Y Avg
2.94
5Y Avg
3.03
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | $1.40B | N/A | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 11.11 | 12.01 | 12.01 | 12.01 |
| Taysha Gene Therapies, Inc. (TSHA)vs › | $1.40B | 17.76 | 8.82 | 5.82 | 10.42 |
| The Pennant Group, Inc. (PNTG)vs › | $1.39B | 1.20 | 1.17 | 1.13 | 1.04 |
| AnaptysBio, Inc. (ANAB)vs › | $1.42B | 5.61 | 9.29 | 11.65 | 16.84 |
| Ultragenyx Pharmaceutical Inc. (RARE)vs › | $1.42B | 1.73 | 2.42 | 2.71 | 3.73 |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.37B | 5.07 | 3.94 | 5.82 | 5.62 |
| Certara, Inc. (CERT)vs › | $1.44B | 2.55 | 2.09 | 2.53 | 2.95 |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 3.02 | 3.13 | 2.94 | 3.03 |
| Omeros Corporation (OMER)vs › | $1.34B | 1.95 | 2.22 | 2.95 | 3.45 |
Current Ratio
N/A
Quick Ratio
N/A
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
